FDA names drugmakers accused of blocking cheaper generics


TRENTON, N.J. (AP) — U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.
The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, some carrying six-figure annual price tags, who are under scrutiny. The agency also lists how many inquiries it has received from generic drugmakers who say they are having trouble getting access to the brand-name drugs.
Generic drug companies generally require 1,000 to 1,500 units, such as pills, of... read more

 
17 May 2018 in Health, Views: 40
Source: Chron
 


News Widget for Webmasters

Newsrt at twitter

«
»
Mo Tu We Th Fr Sa Su
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31